Virginia statute
Va. Code Ann. § 54.1-3442.1 — Definitions
Current through 2026 Regular Session
Part of Article 4.1: Expanded Access to Investigational Drugs, Biological Products, and Devices, Code of Virginia.
Full text of Va. Code Ann. § 54.1-3442.1
Statutory text current through the 2026 Regular Session. This publication reproduces the text of the Code of Virginia from the official Virginia Law Portal API published by the Virginia General Assembly's Division of Legislative Automated Systems; it is not the official Code of Virginia.
As used in this article, unless the context requires a different meaning:
"Investigational drug, biological product, or device" means a drug, biological product, or device that has successfully completed Phase I of a clinical trial but has not been approved for general use by the U.S. Food and Drug Administration and remains under investigation in a clinical trial.
"Terminal condition" means a condition caused by injury, disease, or illness from which, to a reasonable degree of medical probability, a patient cannot recover and (i) the patient's death is imminent or (ii) the patient is in a persistent vegetative state.
"Treating physician" means a physician who is providing or has previously provided medical treatment or evaluation to and has or previously had an ongoing treatment relationship with the person.
Official sources
Legal terms used in this section
This reference is informational and is not legal advice.